These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19526084)

  • 1. The emerging role of IG-IMRT for palliative radiotherapy: a single-institution experience.
    Samant R; Gerig L; Montgomery L; Macrae R; Fox G; Nyiri B; Carty K; Macpherson M
    Curr Oncol; 2009 May; 16(3):40-5. PubMed ID: 19526084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definitive Upfront Stereotactic Ablative Radiotherapy Combined with Image-Guided, Intensity Modulated Radiotherapy (IG-IMRT) or IG-IMRT Alone for Locally Advanced Non-Small Cell Lung Cancer.
    Chi A; Wen S; Monga M; Almubarak M; He X; Rojanasakul Y; Tse W; Remick SC
    PLoS One; 2016; 11(9):e0162453. PubMed ID: 27611833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image-guided intensity-modulated radiotherapy (IG-IMRT) for biliary adenocarcinomas: Initial clinical results.
    Fuller CD; Dang ND; Wang SJ; Desai P; Choi M; Thomas CR; Fuss M
    Radiother Oncol; 2009 Aug; 92(2):249-54. PubMed ID: 19324442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of image-guided intensity-modulated radiotherapy for spinal tumors.
    Yamada Y; Lovelock DM; Bilsky MH
    Neurosurgery; 2007 Aug; 61(2):226-35; discussion 235. PubMed ID: 17762734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image-guided intensity-modulated radiotherapy improves short-term survival for abdominal lymph node metastases from hepatocellular carcinoma.
    Zhang H; Chen Y; Hu Y; Yang P; Wang B; Zhang J; Sun J; Zeng Z
    Ann Palliat Med; 2019 Nov; 8(5):717-727. PubMed ID: 31865732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective comparison of outcome and toxicity of preoperative image-guided intensity-modulated radiotherapy versus conventional pelvic radiotherapy for locally advanced rectal carcinoma.
    Huang CM; Huang MY; Tsai HL; Huang CW; Ma CJ; Lin CH; Huang CJ; Wang JY
    J Radiat Res; 2017 Mar; 58(2):247-259. PubMed ID: 27738080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Image-Guided Intensity-Modulated Radiotherapy and Low-dose Rate Brachytherapy with or without External Beam Radiotherapy in Patients with Localized Prostate Cancer.
    Tsubokura T; Yamazaki H; Masui K; Sasaki N; Shimizu D; Suzuki G; Nakamura S; Yamada K; Okihara K; Shiraishi T; Yoshida K; Nishikawa T; Okabe H
    Sci Rep; 2018 Jul; 8(1):10538. PubMed ID: 30002393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery.
    Ghilezan M; Yan D; Liang J; Jaffray D; Wong J; Martinez A
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1602-10. PubMed ID: 15590192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An age-corrected matched-pair study of erectile function in patients treated with dose-escalated adaptive image-guided intensity-modulated radiation therapy vs. high-dose-rate brachytherapy for prostate cancer.
    Marina O; Warner J; Ye H; Grills IS; Shah C; Wallace M; Gustafson GS; Brabbins DS; Martinez AA; Krauss DJ
    Brachytherapy; 2014; 13(2):163-8. PubMed ID: 24295963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic bone anatomy vs implanted gold seed marker registration for image-guided intensity modulated radiotherapy for prostate carcinoma: Comparative analysis of inter-fraction motion and toxicities.
    Rastogi M; Nanda SS; Gandhi AK; Dalela D; Khurana R; Mishra SP; Srivastava A; Farzana S; Bhatt MLB; Husain N
    J Egypt Natl Canc Inst; 2017 Dec; 29(4):185-190. PubMed ID: 29129577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Image-guided Intensity-modulated Radiotherapy on Patients With Head and Neck Soft-tissue Sarcoma.
    Elsayad K; Stockmann D; Channaoui M; Scobioala S; Grajda A; Berssenbrügge H; Huss S; Moustakis C; Haverkamp U; Kleinheinz J; Lenz G; Wardelmann E; Eich HT
    In Vivo; 2019; 33(4):1293-1300. PubMed ID: 31280221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Dose-Rate Brachytherapy Monotherapy versus Image-Guided Intensity-Modulated Radiotherapy with Helical Tomotherapy for Patients with Localized Prostate Cancer.
    Yamazaki H; Masui K; Suzuki G; Nakamura S; Shimizu D; Nishikawa T; Okabe H; Yoshida K; Kotsuma T; Tanaka E; Otani K; Yoshioka Y; Ogawa K
    Cancers (Basel); 2018 Sep; 10(9):. PubMed ID: 30201941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involved-site image-guided intensity modulated versus 3D conformal radiation therapy in early stage supradiaphragmatic Hodgkin lymphoma.
    Filippi AR; Ciammella P; Piva C; Ragona R; Botto B; Gavarotti P; Merli F; Vitolo U; Iotti C; Ricardi U
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):370-5. PubMed ID: 24613810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term decision regret after post-prostatectomy image-guided intensity-modulated radiotherapy.
    Shakespeare TP; Chin S; Manuel L; Wen S; Hoffman M; Wilcox SW; Aherne NJ
    J Med Imaging Radiat Oncol; 2017 Feb; 61(1):141-145. PubMed ID: 27531363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term tumour control in sacral chordoma following high-dose palliative image-guided intensity-modulated radiotherapy (IG-IMRT).
    Jackson A; Scott S; Romanchikova M; Noble DJ; Burnet NG
    BJR Case Rep; 2017; 3(3):20160145. PubMed ID: 30363228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patients.
    Wortel RC; Incrocci L; Pos FJ; Lebesque JV; Witte MG; van der Heide UA; van Herk M; Heemsbergen WD
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):737-44. PubMed ID: 25752386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does image-guided radiotherapy improve toxicity profile in whole pelvic-treated high-risk prostate cancer? Comparison between IG-IMRT and IMRT.
    Chung HT; Xia P; Chan LW; Park-Somers E; Roach M
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):53-60. PubMed ID: 18501530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of an image guided intensity-modulated protocol for post-prostatectomy radiotherapy: planning data and acute toxicity outcomes.
    Chua B; Min M; Wood M; Edwards S; Hoffmann M; Greenham S; Kovendy A; McKay MJ; Shakespeare TP
    J Med Imaging Radiat Oncol; 2013 Aug; 57(4):482-9. PubMed ID: 23870349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
    Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
    Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity after post-prostatectomy image-guided intensity-modulated radiotherapy using Australian guidelines.
    Chin S; Aherne NJ; Last A; Assareh H; Shakespeare TP
    J Med Imaging Radiat Oncol; 2017 Dec; 61(6):804-811. PubMed ID: 28623847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.